News

Global Health EDCTP3 explains how collaborative research between Africa and Europe has helped address long-standing gaps in health care.

Global Health EDCTP3 invests €64 million to strengthen disease surveillance systems, train researchers and support faster responses to emerging health threats.

Global Health EDCTP3 received 60 applications by the 17 September 2026 deadline for the second stage of its 2026 calls, mobilising €113 million in pledged contributions.

Global Health EDCTP3 brings together governments, non-profits, pharmaceutical companies and others to tackle major health challenges.

Global Health EDCTP3 has received 38 applications for the EDCTP Prizes 2027, following the 24 September deadline, with submissions received across all seven prize categories.

Global Health EDCTP3 has received 243 applications by the 2 September deadline for the 2026 single-stage call. Applicants have requested nearly €491.7 million in Global Health EDCTP3 funding. The indicative available budget at call closure is €36.6 million.

Registrations are now open for participation in the EDCTP Forum 2027.

Global Health EDCTP3 is investing over €10 million in rapid tests, digital solutions and new approaches to overcome persistent barriers to tuberculosis control.

Global Health EDCTP3 invests €39 million to advance novel antimalarial compounds, a repurposed antiviral, and a triple therapy for severe malaria. Co-funding from Pharmaceutical companies, product development partnerships and research institutions brings the total investment to more than €76 million

In-Kind contributions to Additional Activities (IKAAs) are health research and capacity development projects that EDCTP Association member countries directly fund and manage with their own national funding and align with Global Health EDCTP3 goals.